Neuroinflammation as a risk factor for attention deficit hyperactivity disorder

Geoffrey A. Dunn, Joel Nigg, Elinor Sullivan

Research output: Contribution to journalReview article

Abstract

Attention Deficit Hyperactivity Disorder (ADHD)is a persistent, and impairing pediatric-onset neurodevelopmental condition. Its high prevalence, and recurrent controversy over its widespread identification and treatment, drive strong interest in its etiology and mechanisms. Emerging evidence for a role for neuroinflammation in ADHD pathophysiology is of great interest. This evidence includes 1)the above-chance comorbidity of ADHD with inflammatory and autoimmune disorders, 2)initial studies indicating an association with ADHD and increased serum cytokines, 3)preliminary evidence from genetic studies demonstrating associations between polymorphisms in genes associated with inflammatory pathways and ADHD, 4)emerging evidence that early life exposure to environmental factors may increase risk for ADHD via an inflammatory mechanism, and 5)mechanistic evidence from animal models of maternal immune activation documenting behavioral and neural outcomes consistent with ADHD. Prenatal exposure to inflammation is associated with changes in offspring brain development including reductions in cortical gray matter volume and the volume of certain cortical areas –parallel to observations associated with ADHD. Alterations in neurotransmitter systems, including the dopaminergic, serotonergic and glutamatergic systems, are observed in ADHD populations. Animal models provide strong evidence that development and function of these neurotransmitters systems are sensitive to exposure to in utero inflammation. In summary, accumulating evidence from human studies and animal models, while still incomplete, support a potential role for neuroinflammation in the pathophysiology of ADHD. Confirmation of this association and the underlying mechanisms have become valuable targets for research. If confirmed, such a picture may be important in opening new intervention routes.

Original languageEnglish (US)
Pages (from-to)22-34
Number of pages13
JournalPharmacology Biochemistry and Behavior
Volume182
DOIs
StatePublished - Jul 1 2019

Fingerprint

Attention Deficit Disorder with Hyperactivity
Animals
Neurotransmitter Agents
Association reactions
Pediatrics
Polymorphism
Brain
Genes
Chemical activation
Animal Models
Cytokines
Inflammation
Environmental Exposure
Genetic Association Studies
Comorbidity
Mothers

Keywords

  • Maternal immune activation
  • Neurodevelopmental

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this

Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. / Dunn, Geoffrey A.; Nigg, Joel; Sullivan, Elinor.

In: Pharmacology Biochemistry and Behavior, Vol. 182, 01.07.2019, p. 22-34.

Research output: Contribution to journalReview article

@article{4f326772dccb4b33b42fa25eacd03805,
title = "Neuroinflammation as a risk factor for attention deficit hyperactivity disorder",
abstract = "Attention Deficit Hyperactivity Disorder (ADHD)is a persistent, and impairing pediatric-onset neurodevelopmental condition. Its high prevalence, and recurrent controversy over its widespread identification and treatment, drive strong interest in its etiology and mechanisms. Emerging evidence for a role for neuroinflammation in ADHD pathophysiology is of great interest. This evidence includes 1)the above-chance comorbidity of ADHD with inflammatory and autoimmune disorders, 2)initial studies indicating an association with ADHD and increased serum cytokines, 3)preliminary evidence from genetic studies demonstrating associations between polymorphisms in genes associated with inflammatory pathways and ADHD, 4)emerging evidence that early life exposure to environmental factors may increase risk for ADHD via an inflammatory mechanism, and 5)mechanistic evidence from animal models of maternal immune activation documenting behavioral and neural outcomes consistent with ADHD. Prenatal exposure to inflammation is associated with changes in offspring brain development including reductions in cortical gray matter volume and the volume of certain cortical areas –parallel to observations associated with ADHD. Alterations in neurotransmitter systems, including the dopaminergic, serotonergic and glutamatergic systems, are observed in ADHD populations. Animal models provide strong evidence that development and function of these neurotransmitters systems are sensitive to exposure to in utero inflammation. In summary, accumulating evidence from human studies and animal models, while still incomplete, support a potential role for neuroinflammation in the pathophysiology of ADHD. Confirmation of this association and the underlying mechanisms have become valuable targets for research. If confirmed, such a picture may be important in opening new intervention routes.",
keywords = "Maternal immune activation, Neurodevelopmental",
author = "Dunn, {Geoffrey A.} and Joel Nigg and Elinor Sullivan",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.pbb.2019.05.005",
language = "English (US)",
volume = "182",
pages = "22--34",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Neuroinflammation as a risk factor for attention deficit hyperactivity disorder

AU - Dunn, Geoffrey A.

AU - Nigg, Joel

AU - Sullivan, Elinor

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Attention Deficit Hyperactivity Disorder (ADHD)is a persistent, and impairing pediatric-onset neurodevelopmental condition. Its high prevalence, and recurrent controversy over its widespread identification and treatment, drive strong interest in its etiology and mechanisms. Emerging evidence for a role for neuroinflammation in ADHD pathophysiology is of great interest. This evidence includes 1)the above-chance comorbidity of ADHD with inflammatory and autoimmune disorders, 2)initial studies indicating an association with ADHD and increased serum cytokines, 3)preliminary evidence from genetic studies demonstrating associations between polymorphisms in genes associated with inflammatory pathways and ADHD, 4)emerging evidence that early life exposure to environmental factors may increase risk for ADHD via an inflammatory mechanism, and 5)mechanistic evidence from animal models of maternal immune activation documenting behavioral and neural outcomes consistent with ADHD. Prenatal exposure to inflammation is associated with changes in offspring brain development including reductions in cortical gray matter volume and the volume of certain cortical areas –parallel to observations associated with ADHD. Alterations in neurotransmitter systems, including the dopaminergic, serotonergic and glutamatergic systems, are observed in ADHD populations. Animal models provide strong evidence that development and function of these neurotransmitters systems are sensitive to exposure to in utero inflammation. In summary, accumulating evidence from human studies and animal models, while still incomplete, support a potential role for neuroinflammation in the pathophysiology of ADHD. Confirmation of this association and the underlying mechanisms have become valuable targets for research. If confirmed, such a picture may be important in opening new intervention routes.

AB - Attention Deficit Hyperactivity Disorder (ADHD)is a persistent, and impairing pediatric-onset neurodevelopmental condition. Its high prevalence, and recurrent controversy over its widespread identification and treatment, drive strong interest in its etiology and mechanisms. Emerging evidence for a role for neuroinflammation in ADHD pathophysiology is of great interest. This evidence includes 1)the above-chance comorbidity of ADHD with inflammatory and autoimmune disorders, 2)initial studies indicating an association with ADHD and increased serum cytokines, 3)preliminary evidence from genetic studies demonstrating associations between polymorphisms in genes associated with inflammatory pathways and ADHD, 4)emerging evidence that early life exposure to environmental factors may increase risk for ADHD via an inflammatory mechanism, and 5)mechanistic evidence from animal models of maternal immune activation documenting behavioral and neural outcomes consistent with ADHD. Prenatal exposure to inflammation is associated with changes in offspring brain development including reductions in cortical gray matter volume and the volume of certain cortical areas –parallel to observations associated with ADHD. Alterations in neurotransmitter systems, including the dopaminergic, serotonergic and glutamatergic systems, are observed in ADHD populations. Animal models provide strong evidence that development and function of these neurotransmitters systems are sensitive to exposure to in utero inflammation. In summary, accumulating evidence from human studies and animal models, while still incomplete, support a potential role for neuroinflammation in the pathophysiology of ADHD. Confirmation of this association and the underlying mechanisms have become valuable targets for research. If confirmed, such a picture may be important in opening new intervention routes.

KW - Maternal immune activation

KW - Neurodevelopmental

UR - http://www.scopus.com/inward/record.url?scp=85066241104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066241104&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2019.05.005

DO - 10.1016/j.pbb.2019.05.005

M3 - Review article

VL - 182

SP - 22

EP - 34

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

ER -